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Restenosis following vascular injury remains a pressing clinical problem, despite continuous improvements in analysis of predictive markers and trials of new therapeutic strategies. In particular, the introduction of drug-eluting stents (DES) was initially welcome as the solution for long-term restenosis
and relegated all other therapeutic approaches to the background. However, it is gradually emerging that rates of late restenosis and thrombosis after the use of DES are higher than suggested by initial experience [2] .
Furthermore, angioplasty cannot be always considered the best procedure, depending on the number and localisation of arterial lesions and on comorbidities. In this concern, it has been Expression profiles in surgically-induced carotid stenosis: a combined transcriptomic and proteomic investigation [4] .
In this context, experimental carotid surgical injury remains a major tool, to dissect the molecular pathways involved in stenosis progression and to identify novel potential targets for (re)stenosis limitation. We set up and validated an arteriotomy model of surgical injury of rat common carotid [5] that has also been used to verify the effectiveness of locally applied antirestenosis drugs [6] . [7] . This is the first study combining a transcriptomic and proteomic analysis of differential gene expression in a model of (re)stenosis, and more precisely during the acute phase that follows carotid arteriotomy, using high-density microarrays and Real Time RT 
This model mimics the injury affecting the arteries submitted to grafting or endarterectomy, since it is characterized by an interruption of the internal and external elastic lamina, which is considered clinically relevant for the development of arterial stenosis. Our model of arteriotomy, as well as the large majority of studies conducted in animal models of vascular injury, has been applied on healthy, non-stenotic vessels. The exacerbate reparative mechanisms occurring after vascular injury in healthy or atherosclerotic vessels have a common basis, even if with possible differences related to basal increased inflammation, endothelial dysfunction and proliferative activity. Transcriptome and proteome feed back to each other in a highly complex way. To begin to understand the regulatory interactions between transcriptome and proteome, a comparative approach including the simultaneous analysis of expression at the RNA and protein level is required. So far, comparative and transcriptome and proteome analyses have been conducted mainly on cultured prokaryotic and eukaryotic cells, while data obtained in complex organisms are very limited
-PCR for mRNA analysis and bidimensional (2D)-gel electrophoresis followed by liquid chromatography (LC) and tandem mass spectrometry (MS/MS) for protein identification.
Our microarray data included a number of genes that could represent new putative targets for prevention of surgically induced stenosis and showed a partial correlation with proteomics data, confirming the complementarities of both approaches. No. 85-23, revised 1996) . All protocols were approved by the Animal Care and Use Committee of the Second University of Naples. Rats were acclimatized and quarantined for at least 1 week before undergoing surgery.
Methods
Animals
Studies were carried out on 12-week-old inbred male WKY rats (300-310 g) (Charles Rivers, France). All animals were handled in compliance with the 'Guide for the Care and Use of Laboratory Animals' published by the US National Institute of Health (NIH publication
Vascular injury
Arteriotomy of rat common carotid artery was performed as already published [6] . Briefly Figure 4A and B. The core of the network in Figure 4A is 
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gradual proliferation of Smooth Muscle Cells (SMC) and accumulation of new elastin laminae concomitant with disruption and fragmentation of pre-existing fibres was also observed in the injured media and adventitia (Fig. 1). SMCs and their switching from fully differentiated to proliferating synthetic phenotype were identified in arteriotomy-injured carotids by confocal immunohistochemistry for SM22, an early marker of differentiated SMCs (data not shown). Morphometric analysis revealed a progressive lumen reduction, with a maximal 60 Ϯ 9% narrowing 30 days after arteriotomy (P < 0.05).
Microarray transcriptome analysis in arteriotomy-injured carotids
constituted by genes involved in MAPK signalling (green line), cell adhesion (yellow line) and focal adhesion (red line). Among the results we obtained, inflammation-related genes were over-represented, in particular 4 hrs and 48 hrs after arteriotomy, when about 70 genes resulted to be activated. Also the magnitude of their FC was greater 4hrs after injury. Among interleukines (IL), we detected a maximal
Fig. 1 Representative cross-sections of rat carotids (hematoxylin-orcein staining, 10ϫ, 40ϫ and 100ϫ magnification). Uninjured carotid (A) and injured carotid harvested (B) 48 hrs and (C) 7 days after arteriotomy.
Bidimensional electrophoresis of proteome in arteriotomy-injured carotids
Proteins were extracted from rat carotids harvested with the same timing used for microarrays and were separated on analytical 2D-gels (Fig. 5) dissection of patterns that could have not been discovered through analysis of individual genes. Microarrays were used in association with a method developed for mRNA linear amplification [8] , that allows the analysis of low amounts of RNA without affecting the fidelity of detection of differential gene expression and the false positive rate [9] [10, 11] .
Microarray technology has already been applied in angioplastyinjured carotids [10, 11] 
Metabolic pathways
Arginine and proline metabolism 6 [12] . It has been estimated that the detection limit of the proteomic approach is to at least 1000 copies of a protein per cell [7] .
9.7E-2 after arteriotomy, while it was permanently down-regulated after angioplasty. This observation, together with the absence of other genes involved in ROS production in angioplasty-injured carotids [10], further supports a sustained oxidative stress induced by arteriotomy. Proteomic analysis resulted in a more limited amount of information in comparison to microarrays (19 identified proteins versus 1163 mRNA differentially expressed in arteriotomy-injured carotids), but it was at level of protein synthesis and provided data also about PTM, that determine to a large extent the function and fate of the protein. Indeed, improper protein modifications might alter the function of the cells, and might be characteristic of the disease. Proteome analysis is still affected by experimental limits, represented by the difficulty in detecting and analyzing very low-abundance proteins (e.g. regulatory proteins), as well as hydrofobic, insoluble, very basic, very small and very large proteins
Proteomic datasets of SMCs [13, 14] and endothelial cells (ECs) [15] represent a useful reference for proteomics in vascular research, but the proteome analysis after tissue injury is still limited [12] . [17] .
The information we obtained with standard proteomics techniques was probably limited also by the characteristics of vascular tissue, in which 90% of proteins is represented by members of the cytoskeleton and contractile apparatus, above all actins, thus making difficult the identification of low-abundant proteins. Because of the very different size of proteome and transcriptome databases obtained from arteriotomy-injured carotids, we did not conduct a global scale correlation analysis of protein and mRNA levels.
Fig. 4 Gene product association networks extracted from the most significant (A) cellular and regulatory process pathways and (B) metabolic pathways involved in arteriotomy-induced carotid stenosis (listed in Table 1). The core of the network in A is constituted by genes involved in MAPK signalling (green line), cell adhesion (red line) and focal adhesion (yellow line). The most significant pathway in B is arginine and proline metabolism. Faded nodes belong to pathways with a P > 0.1. The thickness of the edge is proportional to the number of pathways to which are associated two genes.
The comparison of the functional annotation of the differential proteins and mRNAs identified in arteriotomy-injured carotids suggests that proteomics and microarray detection methods reveal functional categories with different preference (Fig. 7). In more detail, differential microarray analysis of arteriotomy-injured carotids revealed a large number of diverse functions, and signal transduction, nucleic acid metabolism and inflammation GO functional categories include the largest fraction of known mRNAs identified. In contrast, differential proteome analysis revealed a lower number of different functional GO categories, with the cytoskeleton and contractile apparatus, protein metabolism and stress response constituting the largest fraction of identified proteins. This difference is probably related to the experimental limitation of the proteomic techniques and to the higher sensitivity of microarray analysis. Improved proteomic techniques (e.g. Differential In Gel Electrophoresis) will certainly increase resolution and sensitivity, providing adjunctive information at proteome level in the analysis of vascular pathophysiology.
Microarray transcriptome analysis in arteriotomy-injured carotids
Mcp-1 is another soluble pro-inflammatory mediator increased in arteriotomy-injured carotids. Our data are in agreement with studies revealing its rapid increase in the arterial wall and in the circulation after injury [18]. Mcp-1 exerts its effect, at least in part, by inducing ROS generation, which in turn can further enhance the synthesis of Mcp-1 through an autocrine mechanism, and/or evoke a secondary cytokine and growth factor response (Vegf, Igf, Fgf, all induced by arteriotomy) in the injured vascular wall.
Arginase I, classically considered exclusive to the liver, has been found also in other tissues, including the vessels [19] [21] . At later stages, collagen accumulation leads to constrictive remodelling after vascular injury [22] .
. This enzyme, member of a nitric oxide-synthase (NOS)-alternative pathway for L-Arginine breakdown leading to biosynthesis of urea and L-ornithine, plays a role in the regulation of vascular tone and is involved in vascular dysfunctions (e.g. hypertension). To our knowledge, our data highlight for the first time the increase of Arginase I in vascular injury.
The metabolism of collagens and of other ECM proteins is strongly linked to inflammation. In particular, ECM protein synthesis is highly regulated by different cytokines at the transcriptional level. Especially, TGF-␤1, a key player in the pathophysiology of tissue repair, enhances type I collagen gene expression. In contrast, tumour necrosis factor ␣ (TNF-␣), whose matrix-remodelling function is opposite to that of TGF-␤1, reduces type I collagen gene expression [23]. Our microarray data included members of both signalling pathways triggered by these cytokines (e.g. mothers against decapentaplegic homologs (SMAD)).
The collagen prolyl 4-hydroxylases (P4Hs), enzymes residing within the endoplasmic reticulum, have a central role in the biosynthesis of collagens [24] . Microarray data included a significant [10] . The role of cathepsins B and Z in arterial stenosis remains to be further elucidated. 
